• miR-18a/ALOXE3 Axis: Ferroptosis and Migration in Glioblasto

  2026-04-20

  This study uncovers how miR-18a promotes glioblastoma by suppressing ALOXE3, diminishing ferroptosis and enhancing tumor cell migration through altered lipid signaling. The findings reveal mechanistic links between microRNA regulation, ferroptotic vulnerability, and G protein-coupled signaling, suggesting new molecular targets for glioblastoma intervention.

• Baicalin: Pathway Modulation for Neuroplasticity and Cancer

  2026-04-20

  Baicalin, a flavone glycoside from Scutellaria baicalensis, is redefining the landscape of translational research through precise modulation of KEAP1-NRF2/HO-1 and TGF-β1/p-Smad3 signaling pathways. This article integrates mechanistic insight, recent evidence in neuroplasticity and oncology, and strategic guidance for translational researchers. It highlights how Baicalin enables restoration of adult cortical plasticity and cancer sensitization, drawing on preclinical breakthroughs and validated workflows. By situating Baicalin within the current competitive and regulatory landscape, we provide actionable recommendations and a visionary outlook for translational teams seeking to harness its full potential.

• Applied Workflows Using mCherry mRNA for Reliable Cell Marki

  2026-04-19

  EZ Cap™ mCherry mRNA (5mCTP, ψUTP) delivers bright, reproducible red fluorescence with suppressed immune activation, ideal for reporter assays and cell tracking. Discover how advanced cap structure and modified nucleotides streamline experimental design and troubleshooting in demanding cell systems.

• Exo1: Advancing Precision in Exocytic Pathway Inhibition

  2026-04-18

  This thought-leadership article explores how Exo1 (methyl 2-(4-fluorobenzamido)benzoate) is redefining membrane trafficking inhibition for translational researchers, with a focus on mechanistic specificity, experimental rigor, and its unique value in tumor extracellular vesicle (TEV) studies. Integrating recent literature on TEV-mediated metastasis and internal knowledge assets, this piece offers in-depth guidance for optimizing exocytosis assays and highlights future directions for preclinical research.

• Early Life Adversity, Oxytocin, and Innate Defensive Behavio

  2026-04-17

  This article reviews a recent study revealing that early life adversity (ELA) impairs visually evoked innate defensive behaviors in mice via disruption of oxytocin signaling in the superior colliculus. The findings establish a mechanistic link between early social deprivation, oxytocin receptor downregulation, and behavioral deficits, offering new insights into the neurobiological consequences of ELA and potential intervention targets.

• Hepatic sEH Regulates Osteoclastogenesis via Nrf2 in Osteopo

  2026-04-16

  This study uncovers a novel mechanism by which hepatic soluble epoxide hydrolase (sEH) modulates osteoclast differentiation and bone homeostasis through suppression of the Nrf2 signaling pathway. The findings link the liver-bone axis, epoxyeicosatrienoic acids metabolism, and redox balance to osteoporosis pathogenesis, suggesting new research avenues for chronic inflammation and bone disease.

• Sumatriptan Succinate: Systematic Review of Anti-Inflammator

  2026-04-15

  This systematic review comprehensively evaluates sumatriptan’s anti-inflammatory properties, highlighting its modulation of cytokines and signaling pathways beyond migraine relief. The findings support potential repositioning of this selective 5-HT1 receptor agonist as a research tool in inflammation models, offering mechanistic insights and practical dosage benchmarks for experimental designs.

• Lipid Scrambling Regulates Ferroptosis and Tumor Immunity

  2026-04-14

  Yang et al. identified TMEM16F-mediated lipid scrambling as a key suppressor of ferroptosis, revealing its critical role in plasma membrane remodeling and tumor immune rejection. These findings illuminate execution-phase ferroptosis mechanisms and offer new avenues for therapeutic strategies targeting membrane dynamics in cancer.

• BMX-IN-1: Selective BMX Kinase Inhibitor for Cancer & TB Mod

  2026-04-13

  BMX-IN-1 is a highly selective, irreversible BMX kinase inhibitor with demonstrated potency in cell cycle arrest and apoptosis induction in cancer research. Recent evidence links BMX kinase to lysosomal acidification, highlighting BMX-IN-1's unique utility for both oncology and infectious disease studies. This article details mechanistic, workflow, and benchmarking data for BMX-IN-1, with direct application to prostate cancer and TB host-pathogen models.

• Transmission of Carbapenemase Genes in Enterobacter cloacae:

  2026-04-12

  This multicenter study delineates the prevalence, genetic localization, and dissemination mechanisms of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae from eight hospitals in Guangdong, China. The findings reveal high rates of multidrug resistance, particularly associated with the blaNDM−1 gene, and underscore the rapid horizontal transfer of resistance genes, with significant clinical and laboratory implications for antibacterial research.

• Disrupting SARS-CoV-2 Nucleocapsid Condensation: GCG as a Mo

  2026-04-12

  The reference study reveals that the SARS-CoV-2 nucleocapsid protein (N) undergoes RNA-driven liquid–liquid phase separation (LLPS), a process critical for viral replication and assembly. Importantly, the polyphenol GCG from green tea disrupts this condensation, providing new molecular insight and potential strategies for antiviral intervention.

• Thioguanine Workflows: Precision in Cancer and Antiviral Res

  2026-04-11

  Thioguanine (6-thioguanine) delivers dual-action impact, enabling highly targeted workflows for both cancer and antiviral studies. Discover protocol enhancements, troubleshooting strategies, and data-driven insights to unlock robust inhibition of DNA synthesis and epigenetic modulation in your experimental designs.

• γH2AX DNA Damage Detection Kit: Precision DNA Damage Biomark

  2026-04-11

  Leverage the γH2AX DNA Damage Detection Kit (Mouse mAb/Red) to achieve sensitive, high-throughput detection of DNA double-strand breaks in research workflows. This article translates recent radiobiology advances and practical troubleshooting into actionable guidance for maximizing assay reliability in DNA repair, apoptosis, and genotoxicity studies.

• Advancing Genomic Instability Research: γH2AX DNA Damage ...

  2026-04-10

  Explore how the γH2AX DNA Damage Detection Kit (Mouse mAb/Red) revolutionizes DNA double-strand break detection and DNA damage response research. This in-depth analysis reveals unique mechanistic insights, advanced applications, and strategic guidance for genomic instability studies.

• Scenario-Based Insights: γH2AX DNA Damage Detection Kit (...

  2026-04-09

  This article explores practical laboratory scenarios where the γH2AX DNA Damage Detection Kit (Mouse mAb/Red), SKU K2275, provides robust solutions for DNA double-strand break detection, apoptosis assays, and genomic instability analysis. By grounding discussion in real experimental challenges and validated best practices, it demonstrates how SKU K2275 elevates workflow reproducibility and data confidence in biomedical research.

407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page